ADVANZ PHARMA

ADVANZ PHARMA

ADVANZ PHARMA Corp. Limited, a pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products worldwide. The company operates through two segments: ADVANZ PHARMA International and ADVANZ PHARMA North America. Its ADVANZ PHARMA International segment offers a portfolio of branded and generic prescription products to wholesalers, distributors, hospitals, and pharmacies. This segment's products include Brinavess for the conversion of onset... atrial fibrillation to sinus rhythm in adults; Aggrastat, a reversible GP IIb/IIIa inhibitor indicated for use in patients with acute coronary syndrome; Xydalba, a semi-synthetic lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections in adults; and Zevtera/Mabelio, a cephalosporin antibiotic for the treatment of community-acquired and hospital-acquired pneumonia. The company's ADVANZ PHARMA North America segment provides Donnatal for the treatment of irritable bowel syndrome; Zonegran for the treatment of partial seizures in adults with epilepsy; Nilandron for the treatment of metastatic prostate cancer; Lanoxin for the treatment of mild to moderate heart failure and atrial fibrillation; Plaquenil for the treatment of lupus and rheumatoid arthritis; and Photofrin for the treatment of certain types of cancer. It also offers Prostaglandin E1 formulations for the treatment of erectile dysfunction and peripheral arterial occlusive disease under the Prostavasin, Viridal, Vasaprostan, and Edex brands, as well as holds licensed commercialization rights to a pre-registration drug/device combination product, Trevyent for the treatment of pulmonary arterial hypertension. It sells its products through direct sales and local distribution relationships. The company was formerly known as ADVANZ PHARMA Corp. and changed its name to ADVANZ PHARMA Corp. Limited in December 2019. ADVANZ PHARMA Corp. Limited is headquartered in London, the United Kingdom.

Advanz Pharma_logo

Industry:
Pharmaceutical Company

Address:
Capital House, London, United Kingdom Zipcode EC4N 7BL

Country:
United Kingdom

Phone:
44 2085 889 100

Market Cap:
822.24M
Total Revenue:
525.58M
Total Assets:
1.58B
Total Cash:
160.19M

Subsidiaries: AMCo (Formerly Amdipharm Mercury Ltd) · Correvio Pharma Corp · Correvio


Key Executives
Name Title Pay Year Born
Mr. Graeme Neville Duncan CEO & Exec. Director 1,258,797$ 1975(45 years old)
Mr. Adeel Ahmad CFO & Exec. Director 752,732$ 1975(45 years old)
Mr. Karl Ian Belk Chief Operations Officer 685,795$ 1969(51 years old)
Mr. Robert Sully Gen. Counsel 669,749$ 1974(46 years old)
Mr. Paul Burden Chief Commercial Officer of Strategic Growth Unit 638,957$ 1975(45 years old)
Mr. Adam Peeler VP of Investor Relations & Communications N/A N/A
Mr. Guy Clark Chief Corp. Devel. Officer N/A 1971(49 years old)
Mr. Arijit Mookerjee MD and CFO of CPI & CLI N/A N/A
Mr. Andrew Patrick Hoyt Chief Financial Officer of US Bus.es N/A N/A
Mr. Robert D. Ford MD & Sr. Director of Legal Affairs of CPI and CLI N/A 1967(53 years old)



Financial & Stock
Exchange Other OTC. Currency in USD. Market state POSTPOST
According to Advanz Pharma's financial reports the company's revenue in 2020 were 525.58M an increase( +3.35%) over the years 2019 revenue that were of 508.32M. In 2020 the company's total earnings were -74.86M while total earnings in 2019 were -196.02M(-62.24%).
Company's stock symbol is CXRXF. Lastest price : 16.81. Total volume :2.46k Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.advanzpharma.com

  • Host name: advanzpharma.com
  • IP address: 178.128.160.224
  • Location: London United Kingdom
  • Latitude: 51.5353
  • Longitude: -0.6658
  • Timezone: Europe/London
  • Postal: SL1

Loading ...
Loading ...


More informations about "Advanz Pharma" on Search Engine

Homepage | Advanz Pharmaceutical

Advanzpharma.com ADVANZ PHARMA is a global pharmaceutical company that’s committed to helping patients lead healthier, better lives by enabling patients and healthcare providers to access high-quality niche, established medicines.

Homepage | Advanz Pharmaceutical

Advanzpharma.com ADVANZ PHARMA Corp Limited 11-15 Seaton Place St Helier Jersey JE4 0QH. Direct: …

Homepage | Advanz Pharmaceutical

Advanzpharma.com ADVANZ PHARMA® is a global pharmaceutical company that’s committed …

Homepage | Advanz Pharmaceutical

Advanzpharma.com ADVANZ PHARMA takes its Environmental, Social & Governance (ESG) responsibilities …

Homepage | Advanz Pharmaceutical

Advanzpharma.com these materials are not directed at or to be accessed by persons resident in any …

Homepage | Advanz Pharmaceutical

Advanzpharma.com ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2020 Results. 17 Mar …

Homepage | Advanz Pharmaceutical

Advanzpharma.com ADVANZ PHARMA. Direct: +1 847 283 7690 Fax: +1 847 283 7695. …

Homepage | Advanz Pharmaceutical

Advanzpharma.com Advanz Pharma Corp. Limited – Management Discussion and Analysis – 6 November …

Homepage | Advanz Pharmaceutical

Advanzpharma.com these materials are not directed at or to be accessed by persons resident in any …

Advanz Pharma - Wikipedia

En.wikipedia.org ADVANZ PHARMA Corp. is a multi-national pharmaceutical company headquartered in London. It changed its name from Concordia Healthcare Corp. in November 2018. The company focuses on a number of therapy areas including endocrinology, ophthalmology, urology, anti-infectives, pain management, central nervous system disorders, oncology, haematology, cardiology and intensive care medicine. The company also focuses on acquiring legacy pharmaceutical compounds which are usually off patent. AD…

ADVANZ PHARMA CORP LTD (JY) (CXRXF) Stock Price, News

Finance.yahoo.com ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2020 Results. ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company") (TSX: ADVZ), a global pharmaceutical company with a strategic ...

Advanz Pharmaceutical| Advanz Pharma

Advanzpharma.com 1 day ago · ADVANZ PHARMA is a specialty pharmaceutical company with a strategic focus on complex medicines in Europe. With deep expertise in Anti-Infectives, Endocrinology and Cardiovascular, ADVANZ PHARMA is a specialist partner in commercialising complex medicines to European hospitals.

CXRXF Stock Price | Advanz Pharma Corp. Ltd. Stock Quote

Marketwatch.com Apr 09, 2021 · ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company, which engages in the provision of branded and unbranded products. The firm specializes in …

advanzpharma.in - Quality Control

Advanzpharma.in Advanz Pharma that promote good health for all by providing quality medicines at affordable price. We are proud to introduce some innovation formulations along with commonly fixed-dose combinations.

Advanz Pharmaceutical| Advanz Pharma

Advanzpharma.com Jan 27, 2021 · ADVANZ PHARMA is a specialty pharmaceutical company with a strategic focus on complex medicines in Europe.

Nordic Capital offers to buy Advanz Pharma in $846 million

Nasdaq.com Jan 27, 2021 · Jan 27 (Reuters) - Nordic Capital on Wednesday offered to buy Advanz Pharma, valuing it at $846 million and taking a lead among private equity firms to …

CXRXF | Advanz Pharma Corp. Ltd. Stock Price & News - WSJ

Wsj.com View the latest Advanz Pharma Corp. Ltd. (CXRXF) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Endo, Advanz Pharma Partner To Commercialize Xydalba In

Nasdaq.com 1 day ago · Advanz Pharma will be responsible for supplying the drug. Paladin Labs is targeting to launch the product in 2021. Advanz Pharma will provide …

Advanz Pharmaceutical| Advanz Pharma

Advanzpharma.com May 27, 2020 · ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp. 27.05.20 Provides ADVANZ PHARMA with an immediate and direct commercial and medical presence in Germany, France, Spain, Italy, and the Benelux region, while strengthening its existing presence in the Nordics and the United Kingdom

ADVANZ PHARMA | LinkedIn

Linkedin.com With an impressive heritage and experience in supplying over 90 countries with more than 200 medicines, ADVANZ PHARMA strives to go beyond the fulfilment of …

Advanz Pharma - Homepage | BNM Group

Bnmgroup.advanzpharma.com Boucher & Muir Pty Ltd (BNM), an ADVANZ PHARMA company, is an innovative pharmaceutical company delivering sustainable value across our product portfolio to customers in Australia, New Zealand and the South Pacific Islands. BNM commenced business in 1957, a …

BNM Group| Advanz Pharma

Bnmgroup.advanzpharma.com ADVANZ PHARMA is a specialty pharmaceutical company with a strategic focus on complex medicines in Europe. With deep expertise in Anti-Infectives, Endocrinology and Cardiovascular, ADVANZ PHARMA is a specialist partner in commercialising complex medicines to European hospitals.

Advanz Pharma Company Profile: Stock Performance

Pitchbook.com Advanz Pharma Corp Ltd is an international specialty pharmaceutical company, owning or licensing, through its subsidiaries, a diversified portfolio of branded and generic prescription products. The company has two reportable segments, which consist of ADVANZ PHARMA International and ADVANZ PHARMA …

Products | BNM Group - Advanz Pharma

Bnmgroup.advanzpharma.com All products under the Amdipharm and Mercury banner are owned by ADVANZ PHARMA with the majority of the BNM Group products both in Australia and New Zealand being in licensed.

ADVANZ PHARMA Careers: Job Search & Apply

Advanzpharmajobs.com A reactive approach is not enough: your approach must be proactive, innovative and energetic. These are the key factors that underline not only our marketing approach and its customer care focus but also our recruitment processes.

CXRXF Stock Forecast, Price & News (ADVANZ PHARMA)

Marketbeat.com ADVANZ PHARMA Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates in two segments, ADVANZ PHARMA International and ADVANZ PHARMA North America.

ADVANZ PHARMA to Acquire Correvio - PR Newswire

Prnewswire.com Mar 16, 2020 · ADVANZ PHARMA is a global pharmaceutical company with a diversified portfolio of more than 200 branded and unbranded products, and product sales in more 90 countries.

ADVANZ PHARMA Corp. Limited Announces Agreement Of Terms

Prnewswire.com Jan 27, 2021 · LONDON, Jan. 27, 2021 /PRNewswire/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company"), a specialty pharmaceutical company with a strategic focus on complex medicines in Europe, today ...

UPDATE 2-Nordic Capital offers to buy Advanz Pharma | Reuters

Reuters.com Advanz Pharma, which was formed from the 2015 merger of Concordia Healthcare and AMCO, makes drugs used in endocrinology, urology, pain management and cardiology among other therapeutic areas.

About | Abcur English - Advanz Pharma

Abcur.advanzpharma.com Abcur AB is the Nordic division of ADVANZ PHARMA, an international specialty pharmaceutical company with a diversified portfolio of more than 200 patented and off-patent products, sold in over 90 countries.

About | BNM Group - Advanz Pharma

Bnmgroup.advanzpharma.com BNM commenced business in 1957, a family owned and operated company. As an ADVANZ PHARMA company, BNM continues to espouse strong family values and, with its experienced and talented team, is committed to helping patients lead healthier, better lives by enabling patients and healthcare providers to access high-quality, niche, established medicines.

All medicines for ADVANZ Pharma - (emc)

Medicines.org.uk ADVANZ Pharma. Back to top. Address. Capital House, 1st Floor, 85 King William Street, London, EC4N 7BL, UK. Telephone +44 (0)208 588 9131. Medical Information Direct Line. 08700 70 30 33. Customer Care direct line +44 (0)208 588 9273. WWW. www.advanzpharma.com. Fax +44 (0)208 588 9200.

Advanz Pharma reports Q4 results (OTCMKTS:CXRXF) | Seeking

Seekingalpha.com Mar 17, 2021 · Advanz Pharma reports Q4 results Mar. 17, 2021 7:42 AM ET ADVANZ PHARMA Corp. Limited (CXRXF) By: Meghavi Singh , SA News Editor Advanz Pharma ( OTCPK:CXRXF ) : …

Advanz Pharma: Q4 Earnings Snapshot - Yahoo

Finance.yahoo.com Mar 18, 2021 · Advanz Pharma shares have climbed fivefold since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $16.55, a drop of almost 10% in the last 12 months.

ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and

Prnewswire.com Mar 17, 2021 · LONDON, March 17, 2021 /PRNewswire/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company") (TSX: ADVZ), a global pharmaceutical company with a strategic focus on complex medicines in ...

BNM Group| Advanz Pharma

Bnmgroup.advanzpharma.com Mar 17, 2021 · ADVANZ PHARMA is a global pharmaceutical company with a strategic focus on complex medicines in Europe. With an agile and experienced team, including direct sales, marketing and medical capability across many of Europe's major markets, the Company supplies, innovates and enhances the critical medicines patients depend on, ensuring continued ...

ADVANZ PHARMA Corp. Limited Announces Agreement Of Terms

Biospace.com Jan 27, 2021 · LONDON, Jan. 27, 2021 /PRNewswire/ - ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company"), a specialty pharmaceutical company with a strategic focus on complex medicines in Europe, today announced that its board of directors has reached an agreement on the terms of a cash offer, to be made by a subsidiary ("Bidco") of Nordic Capital, pursuant to which Nordic …

ADVANZ PHARMA - Jefferies Group

Jefferies.com ADVANZ PHARMA expects that these estimates will change as new information is received and that actual results will vary from these estimates, possibly by material amounts. While ADVANZ PHARMA may elect to update these estimates at any

ADVANZ PHARMA Corp. Limited Profile - SEDAR

Sedar.com ADVANZ PHARMA Corp. Limited: Mailing Address: Capital House 85 King William Street N/A, London EC4N 7BL: Head Office Address: Capital House 85 King William Street N/A, London EC4N 7BL: Contact Name: Robert Sully - General Counsel: Principal Regulator: Ontario: Business e-mail address: [email protected]: Short Form Prospectus Issuer ...

ADVZ Stock Quote - Advanz Pharma Corp Ltd - Bloomberg Markets

Bloomberg.com Advanz Pharma Corp. Limited operates as a pharmaceutical company. The Company discovers endocrinology, ophthalmology, urology, anti-infectives, pain …

BRIEF-Advanz Pharma And Endo Announce Partnership For

Msn.com * advanz pharma and endo announce partnership for paladin labs to commercialize xydalba (dalbavancin hydrochloride) in canada * endo international plc - advanz pharma will be responsible for ...

Abcur English| Advanz Pharma

Abcur.advanzpharma.com ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2020 Results. 17 Mar 2021. Learn more. Industry Related — Today, ADVANZ have announced the acquisition of the rights to Cyclophosphamide from Zenex Pharma in Australia. 29 Jan 2021. Learn more. Press Announcement 27 January 2021. 27 Jan 2021. Learn more ...

ADVANZ PHARMA Corp. Limited Announces Agreement Of Terms

Morningstar.com Jan 27, 2021 · ADVANZ PHARMA is a specialty pharmaceutical company with a strategic focus on complex medicines in Europe. With an agile and experienced team, …

ADVANZ PHARMA Corp. Limited Closes Acquisition of

Bloomberg.com May 27, 2020 · ADVANZ PHARMA anticipates Correvio's business will be profitable on a pro-forma basis in 2020 through a combination of top-line growth and the …

ADVANZ PHARMA to Acquire Correvio | Nasdaq

Nasdaq.com Mar 16, 2020 · ADVANZ PHARMA operates an international specialty pharmaceutical business with a diversified portfolio of more than 200 branded and unbranded products, and sales in …

ADVANZ PHARMA Careers: Artwork Development Manager - …

Advanzpharmajobs.com Application / data collection forms are produced by Advanz Pharma who, as Data Controller, will use the data collected for the purposes of considering you for suitable employment vacancies, communicating with you at various stages in the selection process (such as to arrange interviews), for OnBoarding successful applicants, and potentially for retaining the applications of unsuccessful ...

ADVANZ PHARMA Careers: Function Head - Regulatory

Advanzpharmajobs.com Application / data collection forms are produced by Advanz Pharma who, as Data Controller, will use the data collected for the purposes of considering you for suitable employment vacancies, communicating with you at various stages in the selection process (such as to arrange interviews), for OnBoarding successful applicants, and potentially for retaining the applications of unsuccessful ...

Advanz Pharma and similar companies | Frankensaurus.com

Frankensaurus.com Advanz Pharma is similar to these companies: Novartis, Sanofi, Telesta Therapeutics and more. Topic. Advanz Pharma. Share. Companies similar to or like Advanz Pharma. Publicly traded pharmaceutical company based in Canada.

fucithalmic.com (English)| Advanz Pharma

Fucithalmic.com ADVANZ PHARMA. Capital House 85 King William Street London EC4N 7BL United Kingdom. General Enquiries Tel: 0044 208 588 9100 [email protected] Please contact Medical Information team for all medical enquiries or reporting of adverse events/products complaints. Tel: 0044 8700 70 30 33 [email protected] ×

Advanz Pharma Reviews | Glassdoor

Glassdoor.com 15 Advanz Pharma reviews. A free inside look at company reviews and salaries posted anonymously by employees.

ADVANZ PHARMA hiring Head Global Regulatory Affairs in

Linkedin.com ADVANZ PHARMA have a great new opportunity for an experienced Head of Global Regulatory Affairs to join the organisation. Consideration will be given to candidates based in the UK or Europe.